{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:14:29Z","timestamp":1790867669948,"version":"4.1.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","bmn.com","cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Endocrinology & Metabolism"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.tem.2024.03.007","type":"journal-article","created":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T12:24:04Z","timestamp":1713356644000},"page":"687-696","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Opportunities and challenges in phage therapy for cardiometabolic diseases"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3582-0127","authenticated-orcid":false,"given":"Koen","family":"Wortelboer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0112-6348","authenticated-orcid":false,"given":"Hilde","family":"Herrema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tem.2024.03.007_bb0005","series-title":"Noncommunicable Diseases Country Profiles 2018","author":"World Health Organization","year":"2018"},{"key":"10.1016\/j.tem.2024.03.007_bb0010","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11886-016-0755-4","article-title":"Genetics of insulin resistance and the metabolic syndrome","volume":"18","author":"Brown","year":"2016","journal-title":"Curr. Cardiol. Rep."},{"key":"10.1016\/j.tem.2024.03.007_bb0015","article-title":"The role of the microbiome in human health and disease: an introduction for clinicians","volume":"356","author":"Young","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.tem.2024.03.007_bb0020","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1136\/gutjnl-2021-326789","article-title":"Gut microbiome and health: mechanistic insights","volume":"71","author":"de Vos","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.tem.2024.03.007_bb0025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41577-022-00727-y","article-title":"The impact of the gut microbiome on extra-intestinal autoimmune diseases","volume":"23","author":"Miyauchi","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.tem.2024.03.007_bb0030","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41579-020-0433-9","article-title":"Gut microbiota in human metabolic health and disease","volume":"19","author":"Fan","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.tem.2024.03.007_bb0035","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1161\/CIRCRESAHA.120.316242","article-title":"Gut microbiota and cardiovascular disease","volume":"127","author":"Witkowski","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.tem.2024.03.007_bb0040","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1161\/CIRCRESAHA.123.322055","article-title":"Gut microbiota and microbial metabolism in early risk of cardiometabolic disease","volume":"132","author":"Gabriel","year":"2023","journal-title":"Circ. Res."},{"key":"10.1016\/j.tem.2024.03.007_bb0045","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/s41579-021-00667-9","article-title":"Microbiome-based therapeutics","volume":"20","author":"Sorbara","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.tem.2024.03.007_bb0050","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.ebiom.2019.05.066","article-title":"Fecal microbiota transplantation beyond Clostridioides difficile infections","volume":"44","author":"Wortelboer","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.tem.2024.03.007_bb0055","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1136\/gutjnl-2016-312297","article-title":"Antibiotics as deep modulators of gut microbiota: between good and evil","volume":"65","author":"Ianiro","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.tem.2024.03.007_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.572912","article-title":"Antibiotics as major disruptors of gut microbiota","volume":"10","author":"Ramirez","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.tem.2024.03.007_bb0065","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.tim.2015.01.006","article-title":"Revisiting phage therapy: new applications for old resources","volume":"23","author":"Nobrega","year":"2015","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.tem.2024.03.007_bb0070","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4292\/wjgpt.v8.i3.162","article-title":"Phage therapy: an alternative to antibiotics in the age of multi-drug resistance","volume":"8","author":"Lin","year":"2017","journal-title":"World J. Gastrointest. Pharmacol. Ther."},{"key":"10.1016\/j.tem.2024.03.007_bb0075","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.3389\/fmicb.2020.01056","article-title":"Phage therapy in Poland - a centennial journey to the first ethically approved treatment facility in Europe","volume":"11","author":"\u017baczek","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.tem.2024.03.007_bb0080","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/s41396-018-0049-5","article-title":"Phage or foe: an insight into the impact of viral predation on microbial communities","volume":"12","author":"Fern\u00e1ndez","year":"2018","journal-title":"ISME J."},{"key":"10.1016\/j.tem.2024.03.007_bb0085","doi-asserted-by":"crossref","first-page":"10771","DOI":"10.1073\/pnas.1305923110","article-title":"Bacteriophage adhering to mucus provide a non-host-derived immunity","volume":"110","author":"Barr","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.tem.2024.03.007_bb0090","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nrmicro2853","article-title":"Going viral: next-generation sequencing applied to phage populations in the human gut","volume":"10","author":"Reyes","year":"2012","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.tem.2024.03.007_bb0095","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.chom.2019.01.017","article-title":"Bacteriophages of the human gut: the \u201cknown unknown\u201d of the microbiome","volume":"25","author":"Shkoporov","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.tem.2024.03.007_bb0100","article-title":"Phages modulate bacterial communities in the human gut following fecal microbiota transplantation","author":"Zuppi","year":"2024","journal-title":"Res. Sq."},{"key":"10.1016\/j.tem.2024.03.007_bb0105","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1053\/j.gastro.2021.02.013","article-title":"Functional restoration of bacteriomes and viromes by fecal microbiota transplantation","volume":"160","author":"Fujimoto","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tem.2024.03.007_bb0110","first-page":"634","article-title":"Bacteriophage transfer during faecal microbiota transplantation in Clostridium difficile infection is associated with treatment outcome","volume":"67","author":"Zuo","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.tem.2024.03.007_bb0115","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.chom.2019.01.019","article-title":"Virome diversity correlates with intestinal microbiome diversity in adult monozygotic twins","volume":"25","author":"Moreno-Gallego","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.tem.2024.03.007_bb0120","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.chom.2019.09.009","article-title":"The human gut virome is highly diverse, stable, and individual specific","volume":"26","author":"Shkoporov","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.tem.2024.03.007_bb0125","doi-asserted-by":"crossref","DOI":"10.1038\/npjbiofilms.2016.10","article-title":"Piggyback-the-winner in host-associated microbial communities","volume":"2","author":"Silveira","year":"2016","journal-title":"NPJ Biofilms Microbiomes"},{"key":"10.1016\/j.tem.2024.03.007_bb0130","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.chom.2018.11.016","article-title":"Dietary fructose and microbiota-derived short-chain fatty acids promote bacteriophage production in the gut symbiont Lactobacillus reuteri","volume":"25","author":"Oh","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.tem.2024.03.007_bb0135","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.tim.2018.10.008","article-title":"Phage therapy: going temperate?","volume":"27","author":"Monteiro","year":"2019","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.tem.2024.03.007_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108142","article-title":"Infection with Bacteroides phage BV01 alters the host transcriptome and bile acid metabolism in a common human gut microbe","volume":"32","author":"Campbell","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.tem.2024.03.007_bb0145","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrmicro.2017.30","article-title":"M\u00e9nage \u00e0 trois in the human gut: interactions between host, bacteria and phages","volume":"15","author":"Mirzaei","year":"2017","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.tem.2024.03.007_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.963173","article-title":"The human gut virome: composition, colonization, interactions, and impacts on human health","volume":"14","author":"Pargin","year":"2023","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.tem.2024.03.007_bb0155","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1101\/gr.122705.111","article-title":"The human gut virome: inter-individual variation and dynamic response to diet","volume":"21","author":"Minot","year":"2011","journal-title":"Genome Res."},{"key":"10.1016\/j.tem.2024.03.007_bb0160","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/nature09199","article-title":"Viruses in the faecal microbiota of monozygotic twins and their mothers","volume":"466","author":"Reyes","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.tem.2024.03.007_bb0165","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.cell.2015.01.002","article-title":"Disease-specific alterations in the enteric virome in inflammatory bowel disease","volume":"160","author":"Norman","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.tem.2024.03.007_bb0170","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/s41564-018-0210-y","article-title":"Murine colitis reveals a disease-associated bacteriophage community","volume":"3","author":"Duerkop","year":"2018","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.tem.2024.03.007_bb0175","article-title":"Enteric phageome alterations in patients with type 2 diabetes","volume":"10","author":"Chen","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.tem.2024.03.007_bb0180","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.3389\/fmicb.2018.03150","article-title":"The human gut virome in hypertension","volume":"9","author":"Han","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.tem.2024.03.007_bb0185","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1038\/s41467-022-31390-5","article-title":"Gut virome profiling identifies a widespread bacteriophage family associated with metabolic syndrome","volume":"13","author":"de Jonge","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tem.2024.03.007_bb0190","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/s41564-018-0166-y","article-title":"Phage puppet masters of the marine microbial realm","volume":"3","author":"Breitbart","year":"2018","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.tem.2024.03.007_bb0195","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.soilbio.2018.09.032","article-title":"Viruses in soil: nano-scale undead drivers of microbial life, biogeochemical turnover and ecosystem functions","volume":"127","author":"Kuzyakov","year":"2018","journal-title":"Soil Biol. Biochem."},{"key":"10.1016\/j.tem.2024.03.007_bb0200","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abn6660","article-title":"Human enteric viruses autonomously shape inflammatory bowel disease phenotype through divergent innate immunomodulation","volume":"7","author":"Adiliaghdam","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.tem.2024.03.007_bb0205","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/s41579-022-00755-4","article-title":"Mutualistic interplay between bacteriophages and bacteria in the human gut","volume":"20","author":"Shkoporov","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.tem.2024.03.007_bb0210","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41385-019-0250-5","article-title":"New insights into intestinal phages","volume":"13","author":"Sausset","year":"2020","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.tem.2024.03.007_bb0215","article-title":"Phages in the gut ecosystem","volume":"11","author":"Zuppi","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.tem.2024.03.007_bb0220","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/s41564-022-01178-w","article-title":"Viral biogeography of the mammalian gut and parenchymal organs","volume":"7","author":"Shkoporov","year":"2022","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.tem.2024.03.007_bb0225","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1057892","article-title":"Phage therapy for Clostridioides difficile infection","volume":"13","author":"Fujimoto","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tem.2024.03.007_bb0230","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S1473-3099(20)30330-3","article-title":"Intravesical bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomised, placebo-controlled, double-blind clinical trial","volume":"21","author":"Leitner","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.tem.2024.03.007_bb0235","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.1016\/S1473-3099(21)00612-5","article-title":"Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review","volume":"22","author":"Uyttebroek","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.tem.2024.03.007_bb0240","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1007\/s00253-017-8224-6","article-title":"Bacteriophage-encoded virion-associated enzymes to overcome the carbohydrate barriers during the infection process","volume":"101","author":"Latka","year":"2017","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.tem.2024.03.007_bb0245","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/s41467-021-27656-z","article-title":"Combination of pre-adapted bacteriophage therapy and antibiotics for treatment of fracture-related infection due to pandrug-resistant Klebsiella pneumoniae","volume":"13","author":"Eskenazi","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tem.2024.03.007_bb0250","doi-asserted-by":"crossref","first-page":"11207","DOI":"10.1073\/pnas.1919888117","article-title":"Pleiotropy complicates a trade-off between phage resistance and antibiotic resistance","volume":"117","author":"Burmeister","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.tem.2024.03.007_bb0255","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev-med-080219-122208","article-title":"Phage therapy for antibiotic-resistant bacterial infections","volume":"73","author":"Hatfull","year":"2022","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.tem.2024.03.007_bb0260","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1016\/j.cell.2022.07.003","article-title":"Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammation","volume":"185","author":"Federici","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.tem.2024.03.007_bb0265","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1038\/s41467-023-39029-9","article-title":"Bacteriophage therapy against pathological Klebsiella pneumoniae ameliorates the course of primary sclerosing cholangitis","volume":"14","author":"Ichikawa","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tem.2024.03.007_bb0270","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41586-019-1742-x","article-title":"Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease","volume":"575","author":"Duan","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.tem.2024.03.007_bb0275","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/s41591-022-02016-6","article-title":"Microbiome-derived ethanol in nonalcoholic fatty liver disease","volume":"28","author":"Meijnikman","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.tem.2024.03.007_bb0280","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.cmet.2019.08.018","article-title":"Fatty liver disease caused by high-alcohol-producing Klebsiella pneumoniae","volume":"30","author":"Yuan","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2024.03.007_bb0285","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1038\/s41467-023-39028-w","article-title":"Bacteriophage targeting microbiota alleviates non-alcoholic fatty liver disease induced by high alcohol-producing Klebsiella pneumoniae","volume":"14","author":"Gan","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tem.2024.03.007_bb0290","doi-asserted-by":"crossref","first-page":"666","DOI":"10.3390\/nu11030666","article-title":"PHAGE study: effects of supplemental bacteriophage intake on inflammation and gut microbiota in healthy adults","volume":"11","author":"Febvre","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.tem.2024.03.007_bb0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcimb.2019.00348","article-title":"Transplanting fecal virus-like particles reduces high-fat diet-induced small intestinal bacterial overgrowth in mice","volume":"9","author":"Lin","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.tem.2024.03.007_bb0300","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12915-020-00906-0","article-title":"Autochthonous faecal viral transfer (FVT) impacts the murine microbiome after antibiotic perturbation","volume":"18","author":"Draper","year":"2020","journal-title":"BMC Biol."},{"key":"10.1016\/j.tem.2024.03.007_bb0305","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1136\/gutjnl-2019-320005","article-title":"Faecal virome transplantation decreases symptoms of type 2 diabetes and obesity in a murine model","volume":"69","author":"Rasmussen","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.tem.2024.03.007_bb0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2023.2236750","article-title":"Fecal virome transplantation is sufficient to alter fecal microbiota and drive lean and obese body phenotypes in mice","volume":"15","author":"Borin","year":"2023","journal-title":"Gut Microbes"},{"key":"10.1016\/j.tem.2024.03.007_bb0315","article-title":"Transfer of modified fecal viromes alleviates symptoms of non-alcoholic liver disease and improve blood glucose regulation in an obesity mouse model","author":"Mao","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.tem.2024.03.007_bb0320","doi-asserted-by":"crossref","first-page":"5600","DOI":"10.1038\/s41467-023-41329-z","article-title":"Phage\u2013microbe dynamics after sterile faecal filtrate transplantation in individuals with metabolic syndrome: a double-blind, randomised, placebo-controlled clinical trial assessing efficacy and safety","volume":"14","author":"Wortelboer","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tem.2024.03.007_bb0325","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.1077275","article-title":"From fecal microbiota transplantation toward next-generation beneficial microbes: the case of Anaerobutyricum soehngenii","volume":"9","author":"Wortelboer","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.tem.2024.03.007_bb0330","doi-asserted-by":"crossref","first-page":"S337","DOI":"10.1093\/cid\/ciad514","article-title":"Towards standardization of phage susceptibility testing: the Israeli Phage Therapy Center \u201cclinical phage microbiology\u201d \u2013 a pipeline proposal","volume":"77","author":"Yerushalmy","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.tem.2024.03.007_bb0335","first-page":"269","article-title":"The Israeli Phage Bank (IPB)","volume":"9","author":"Yerushalmy","year":"2020","journal-title":"Antibiot. (Basel, Switzerland)"},{"key":"10.1016\/j.tem.2024.03.007_bb0340","doi-asserted-by":"crossref","first-page":"e555","DOI":"10.1016\/S2666-5247(21)00127-0","article-title":"Clinical Phage Microbiology: a suggested framework and recommendations for the in vitro matching steps of phage therapy","volume":"2","author":"Gelman","year":"2021","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.tem.2024.03.007_bb0345","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/s41591-019-0437-z","article-title":"Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus","volume":"25","author":"Dedrick","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.tem.2024.03.007_bb0350","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cels.2015.08.013","article-title":"Engineering modular viral scaffolds for targeted bacterial population editing","volume":"1","author":"Ando","year":"2015","journal-title":"Cell Syst."},{"key":"10.1016\/j.tem.2024.03.007_bb0355","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.cell.2019.09.015","article-title":"Engineering phage host-range and suppressing bacterial resistance through phage tail fiber mutagenesis","volume":"179","author":"Yehl","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.tem.2024.03.007_bb0360","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41587-023-01759-y","article-title":"Engineered phage with antibacterial CRISPR-Cas selectively reduce E. coli burden in mice","volume":"42","author":"Gencay","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tem.2024.03.007_bb0365","doi-asserted-by":"crossref","DOI":"10.1128\/jb.00127-23","article-title":"Genetic engineering of resident bacteria in the gut microbiome","volume":"205","author":"Arnold","year":"2023","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.tem.2024.03.007_bb0370","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1038\/s41467-023-39612-0","article-title":"Enhancing bacteriophage therapeutics through in situ production and release of heterologous antimicrobial effectors","volume":"14","author":"Du","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tem.2024.03.007_bb0375","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.3390\/pharmaceutics15061602","article-title":"Eudragit\u00ae FS microparticles containing bacteriophages, prepared by spray-drying for oral administration","volume":"15","author":"Tabare","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.tem.2024.03.007_bb0380","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1473-3099(18)30482-1","article-title":"Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1\/2 trial","volume":"19","author":"Jault","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.tem.2024.03.007_bb0385","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02907-23","article-title":"Stability of magistral phage preparations before therapeutic application in patients with chronic rhinosinusitis, sepsis, pulmonary, and musculoskeletal infections","volume":"11","author":"Uyttebroek","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.tem.2024.03.007_bb0390","doi-asserted-by":"crossref","first-page":"S360","DOI":"10.1093\/cid\/ciad481","article-title":"Magistral phage preparations: is this the model for everyone?","volume":"77","author":"Pirnay","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.tem.2024.03.007_bb0395","series-title":"Guideline on quality, safety and efficacy of veterinary medicinal products specifically designed for phage therapy","author":"Committee for Veterinary Medicinal Products (CVMP)","year":"2023"},{"key":"10.1016\/j.tem.2024.03.007_bb0400","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.coviro.2021.11.005","article-title":"European regulatory aspects of phage therapy: magistral phage preparations","volume":"52","author":"Verbeken","year":"2022","journal-title":"Curr. Opin. Virol."}],"container-title":["Trends in Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276024000833?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276024000833?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T19:45:47Z","timestamp":1723491947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043276024000833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":80,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1043276024000833"],"URL":"https:\/\/doi.org\/10.1016\/j.tem.2024.03.007","relation":{},"ISSN":["1043-2760"],"issn-type":[{"value":"1043-2760","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Opportunities and challenges in phage therapy for cardiometabolic diseases","name":"articletitle","label":"Article Title"},{"value":"Trends in Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tem.2024.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}